Quoin Pharmaceuticals Ltd.
QNRXNasdaqCIK 1671502Healthcare
Reports and events: 281 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2006:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-117080 |
| 2026-10-1406:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-115709 |
| 2026-10-0216:42 ET | DEF 14A | Proxy statementPeriod 2026-11-12 | 0001104659-26-113301 |
| 2026-09-2216:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-109639 |
| 2026-09-1016:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-106705 |
| 2026-08-2810:31 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-102917 |
| 2026-08-2016:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events | 0001104659-26-099239 |
| 2026-08-1416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-097094 |
| 2026-08-1416:02 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-097064 |
| 2026-07-1607:30 ET | DEF 14A | Proxy statementPeriod 2026-08-20 | 0001104659-26-084078 |
| 2026-06-2316:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-076822 |
| 2026-06-0416:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-070501 |
| 2026-05-0716:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-057140 |
| 2026-05-0713:34 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-056941 |
| 2026-03-2616:38 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-035251 |
| 2026-03-2609:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-034951 |
| 2026-03-1116:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-026410 |
| 2026-01-2017:18 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-005127 |
| 2025-11-1717:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-113237 |
| 2025-11-1208:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-109802 |
| 2025-11-0616:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-107785 |
| 2025-11-0616:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107747 |
| 2025-10-2116:40 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-101269 |
| 2025-10-1516:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-099735 |
| 2025-08-2706:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-083248 |
| 2025-08-2117:28 ET | 8-K | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-081480 |
| 2025-08-0716:58 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001410578-25-001613 |
| 2025-08-0716:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-075244 |
| 2025-07-1716:01 ET | DEF 14A | Proxy statementPeriod 2025-08-21 | 0001104659-25-068650 |
| 2025-07-0817:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-066451 |
| 2025-06-2508:56 ET | 8-K | 8.01 Other events | 0001104659-25-062406 |
| 2025-06-2016:30 ET | 8-K | 8.01 Other events | 0001104659-25-061184 |
| 2025-06-0416:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-056378 |
| 2025-05-2317:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-052062 |
| 2025-05-2108:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-051324 |
| 2025-05-1416:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-048579 |
| 2025-05-1316:04 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001410578-25-001226 |
| 2025-04-3017:09 ET | 8-K | 8.01 Other events | 0001104659-25-042661 |
| 2025-04-0416:05 ET | 8-K | 3.03 Change to security holders’ rights | 0001104659-25-032189 |
| 2025-04-0408:30 ET | 8-K | 3.03 Change to security holders’ rights | 0001104659-25-032004 |
| 2025-04-0216:59 ET | 8-K | 8.01 Other events | 0001104659-25-031240 |
| 2025-03-2016:30 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-25-026176 |
| 2025-03-1316:31 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001410578-25-000336 |
| 2025-03-1316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-023447 |
| 2025-02-2716:16 ET | 8-K | 8.01 Other events | 0001104659-25-018234 |
| 2025-02-0416:30 ET | 8-K | 8.01 Other events | 0001104659-25-009137 |
| 2025-01-2816:44 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-006734 |
| 2025-01-2816:43 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-006733 |
| 2025-01-2316:15 ET | 8-K | 8.01 Other events | 0001104659-25-005619 |
| 2025-01-1616:30 ET | 8-K | 8.01 Other events | 0001104659-25-004132 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 20:22 ET. Listed shows no prices and gives no investment advice.